GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nippon Shinyaku Co Ltd (OTCPK:NPPNY) » Definitions » Margin of Safety % (DCF Earnings Based)

Nippon Shinyaku Co (Nippon Shinyaku Co) Margin of Safety % (DCF Earnings Based) : 75.46% (As of May. 14, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Nippon Shinyaku Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2024-05-14), Nippon Shinyaku Co's Predictability Rank is 5-Stars. Nippon Shinyaku Co's intrinsic value calculated from the Discounted Earnings model is $28.52 and current share price is $7.00. Consequently,

Nippon Shinyaku Co's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is 75.46%.

Competitive Comparison of Nippon Shinyaku Co's Margin of Safety % (DCF Earnings Based)

For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Shinyaku Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nippon Shinyaku Co's Margin of Safety % (DCF Earnings Based) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nippon Shinyaku Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Nippon Shinyaku Co's Margin of Safety % (DCF Earnings Based) falls into.


Nippon Shinyaku Co Margin of Safety % (DCF Earnings Based) Calculation

Nippon Shinyaku Co's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(28.52-7.00)/28.52
=75.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.

Nippon Shinyaku Co Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of Nippon Shinyaku Co's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Nippon Shinyaku Co (Nippon Shinyaku Co) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nippon Shinyaku Co Ltd (OTCPK:NPPNY) » Definitions » Margin of Safety % (DCF Earnings Based)
Comparable Companies
TSE:4530 TSE:4581 TSE:4887 TSE:4540 TSE:4506 TSE:4547 TSE:4553 TSE:4521 TSE:4534 TSE:4551 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
4516:Japan
Address
14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto, JPN, 601-8550
Website
http://www.nippon-shinyaku.co.jp
Nippon Shinyaku Co Ltd is a specialty and generic drug manufacturing company. Nippon's research and development activities include a focus on pharmaceuticals, nutraceuticals, safety and pharmacokinetics of drug seeds, genomic drug discovery, and nucleic acid drugs. The company also develops health food ingredients, preservatives, protein preparations, and spices. Nippon considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Nippon Shinyaku Co (Nippon Shinyaku Co) Headlines

No Headlines